NCT01898039 2025-10-02
Modified Vaccine for High Risk or Low Residual Melanoma Patients
Hadassah Medical Organization
Phase 1/2 Recruiting
Clinical Trials
4 trialsNCT05196087 2025-07-02
NIP IT!
University Health Network, Toronto
Recruiting
NCT06875609 2025-03-26
ctDNA in Cutaneous Squamous Cell Carcinoma
Massachusetts Eye and Ear Infirmary
Recruiting
NCT02054104 2022-01-26
Adjuvant Tumor Lysate Vaccine and Iscomatrix With or Without Metronomic Oral Cyclophosphamide and Celecoxib in Patients With Malignancies Involving Lungs, Esophagus, Pleura, or Mediastinum
National Institutes of Health Clinical Center (CC)
Phase 1/2 Terminated